- $1.51bn
- $1.50bn
- $25.10m
- 73
- 18
- 16
- 27
Annual balance sheet for BGM, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 11.9 | 10.5 | 14.3 | 22.4 | 18.1 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 12.6 | 13.5 | 4.87 | 6.35 | 5.77 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 37.5 | 40.4 | 30 | 34.5 | 29.8 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 7.66 | 9.24 | 10.3 | 12.1 | 14.3 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 48.1 | 75.4 | 64.5 | 51.3 | 53 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 18.4 | 18.2 | 9.18 | 6.66 | 8.78 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 22 | 20.5 | 11.5 | 8.47 | 10.3 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 26.1 | 54.9 | 53.1 | 42.8 | 42.7 |
| Total Liabilities & Shareholders' Equity | 48.1 | 75.4 | 64.5 | 51.3 | 53 |
| Total Common Shares Outstanding |